文献速递炎症性肠病消化内镜

内镜下扩张治疗胃十二指肠克罗恩病狭窄的疗效:基于个体患者数据的系统评价与Meta分析

Efficacy of Endoscopic Dilation of Gastroduodenal Crohn's Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-11-29

本研究通过检索Embase、Medline和Cochrane图书馆,收集7个国际转诊中心94例患者共141次内镜下球囊扩张(EBD)的个体数据,分析EBD治疗克罗恩病胃十二指肠狭窄的疗效与安全性。结果显示技术成功率100%,短期临床有效率87%,主要并发症发生率2.9%;中位随访23.1个月期间,70.5%患者症状复发,59.6%需再次扩张,30.8%需手术。

要点

  • EBD治疗上消化道克罗恩病狭窄技术成功率100%,短期临床有效率87%。
  • 主要并发症发生率为2.9%。
  • 中位随访23.1个月,70.5%症状复发,59.6%需再次扩张,30.8%需手术。

核心结论

  • EBD是克罗恩病相关上消化道狭窄的有效手术替代方案,短期技术和临床成功率高,长期疗效中等,并发症率可接受。

研究设计与样本

  • 系统评价与个体患者数据Meta分析,检索Embase、Medline和Cochrane图书馆截至2016年12月的队列研究,纳入7个国际转诊中心94例患者共141次EBD。

主要发现

  • EBD技术成功率为100%,短期临床有效率为87%,主要并发症发生率为2.9%。
  • 中位随访23.1个月,70.5%患者症状复发,59.6%需再次扩张,30.8%需手术干预。
  • 病变位于小肠的患者症状复发风险更高(HR 2.1;P = .003)。
  • 亚洲种族(HR 2.8;P < .001)和小肠病变位置(HR 1.9;P = .004)增加再次扩张需求。
  • 狭窄前扩张是更早需要手术的风险因素(HR 1.9;P = .001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Little is known about the effects of endoscopic balloon dilation (EBD) for strictures of the upper gastrointestinal (UGI) tract in patients with Crohn's disease (CD). We performed a pooled analysis of the efficacy and safety of EBD for UGI CD-associated strictures. METHODS: We searched Embase, Medline, and the Cochrane library, as well as bibliographies of relevant articles, for cohort studies of adults with CD and strictures of the stomach or duodenum (up to the ligament of Treitz) who underwent EBD through December 2016. We obtained data from 7 international referral centers on 94 patients who underwent 141 EBDs. We performed a patient-level meta-analysis of data from published and unpublished cohort studies to determine mechanical and clinical success. We performed a time-to-event analysis to assess symptom recurrence and need for redilation or surgery. The patients analyzed had strictures of the duodenum (n = 107), stomach (n = 30), or spanning both (n = 4). RESULTS: The rate of technical success for EBD was 100%, with 87% short-term clinical efficacy; major complications arose from 2.9% of all procedures. During a median follow-up period of 23.1 months, 70.5% of patients had a recurrence of symptoms, 59.6% required redilation, and 30.8% required surgical intervention. Patients whose disease was located in the small bowel had a higher risk for symptom recurrence (hazard ratio [HR], 2.1; P = .003). Asian race (HR, 2.8; P < .001) and location of disease in the small bowel (HR, 1.9; P = .004) increased the need for redilation. Prestenotic dilation was a risk factor for needing surgery earlier (HR, 1.9; P = .001). CONCLUSIONS: In a meta-analysis, we found EBD for CD-associated strictures of the UGI to be an effective alternative to surgery, with a high rate of short-term technical and clinical success, moderate long-term efficacy, and an acceptable rate of complications.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Bettenworth D, Mücke MM, Lopez R, et al. Efficacy of Endoscopic Dilation of Gastroduodenal Crohn's Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data. Clin Gastroenterol Hepatol. 2018. PMID: 30503966. doi:10.1016/j.cgh.2018.11.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。